Evidence of a role of ANGPTL6 in resting metabolic rate and its potential application in treatment of obesity

Minerva Endocrinologica

Volumn 36, Issue 1, 2011, Pages 13-21

  Mirzaei, K ^a,b   Hossein Nezhad, A ^a   Chamari, M ^b   Shahbazi, S ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Body composition; Calorimetry, indirect; Energy metabolism; Obesity

Indexed keywords

ANGIOPOIETIN RELATED GROWTH FACTOR 6; C REACTIVE PROTEIN; GLUCOSE; GROWTH FACTOR; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASAL METABOLIC RATE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CALORIMETRY; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC RATE; OBESITY; PREDICTION; PROTEIN BLOOD LEVEL; RESTING METABOLIC RATE; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANGIOPOIETINS; BASAL METABOLISM; BIOLOGICAL MARKERS; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; CALORIMETRY, INDIRECT; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDES;

EID: 79959986463     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Waine C. Obesity and type 2 diabetes. British Nutrition Foundation Nutrition Bulletin 2006;31:111-4. (Pubitemid 43805769)
2. Rutkowski J, Davis K, Scherer P. Mechanisms of obesity and related pathologies: the macro- and microcirculation of adipose tissue. FEBS J 2009;276:5738-46.
3. Pittas A, Joseph N, Greenberg A. Adipocytokines and insulin resistance. J Clin Endocrinol Metab 2004;89:447-52.
4. Oike Y, Akao M, Kubota Y, Suda T. Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy. Trends Mol Med 2005;11:473-9. (Pubitemid 41415727)
5. Mirzaei K, Hossein-Nezhad A, Javad Hosseinzadeh-Attar M et al. Visfatin genotype may modify the insulin resistance and lipid profile in type 2 diabetes patients. Minerva Endocrinol 2009;34:273-9.
6. Oike Y, Akao M, Yasunaga K, Yamauchi T, Morisada T, Ito Y et al. Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nat Med. 2005;11:400-8. (Pubitemid 40562330)
7. George J. Angiopoietin-like proteins: another player in the metabolic field. J Hepatol 2006 44:832-4.
8. Kitazawa M, Ohizumi Y, Oike Y, Hishinuma T, Hashimoto S. Angiopoietin-related growth factor suppresses gluconeogenesis through the Akt/forkhead box class O1-dependent pathway in hepatocytes. J Pharmacol Exp Ther 2007;323:787-93. (Pubitemid 350146061)
9. Legry V, Goumidi L, Huyvaert M, Cottel D, Ferrières J, Arveiler D et al. Association between angiopoietin-like 6 (ANGPTL6) gene polymorphisms and metabolic syndrome-related phenotypes in the French MONICA Study. Diabetes Metab 2009;35:287-92.
10. Hato T, Tabata M, Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc Med 2008;18.6-14.
11. Oike Y, Tabata M. Angiopoietin-like proteins-potential therapeutic targets for metabolic syndrome and cardiovascular disease. Circ J 2009;73:2192-7.
12. Oike Y, Ito Y, Maekawa H, Morisada T, Kubota Y, Akao M et al. Angiopoietin-related growth factor (AGF) promotes angiogenesis. Blood 2004;103:3760-5.
13. Ebert T, Bachmann A, , Lössner U, Kratzsch J, Blüher M, Stumvoll M et al. Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis. Metabolism 2009;58:547-51.
14. Apfelbaum M, Bestsarron J, Lacatis D. Effect of caloric restriction and excessive caloric intake on energy expenditure. Am J Clin Nutr 1971;24:1405-9.
15. Connolly J, Romano T, Patruno M. Selections from current literature: effects of dieting and exercise on resting metabolic rate and implications for weight management. Fam Pract. 1999;16:196-201.
16. Bosy-Westphal A, Müller M, Boschmann M, Klaus S, Kreymann G, Lührmann PM et al. Grade of adiposity affects the impact of fat mass on resting energy expenditure in women. Br J Nutr 2009;101:474-7.
17. Puigserver P, Spiegelman B. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): Transcriptional coactivator and metabolic regulator. Endocr Rev 2003;24:78-90. (Pubitemid 36223280)
18. Legry V, Goumidi L, Huyvaert M, Cottel D, Ferrières J, Arveiler D et al. Association between angiopoietin-like 6 (ANGPTL6) gene polymorphisms and metabolic syndrome-related phenotypes in the French MONICA Study. Diabetes Metab 2009;35:287-92.